Mirum Pharmaceuticals, Inc. (MIRM)

NASDAQ: MIRM · Real-Time Price · USD

112.59

+5.02 (4.67%)

Jul 30, 2026, 4:00 PM EDT - Market closed

Mirum Pharmaceuticals Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	569.61	521.31	336.89	186.37	77.06	19.14
Revenue Growth	50.26%	54.74%	80.76%	141.85%	302.67%	-
Gross Profit	463.58	421.07	255.25	139.34	64.69	17.24
Operating Income	-796.42	-22.14	-87.61	-109.15	-131.22	-173.41
Net Income	-798.84	-23.36	-87.94	-163.42	-135.67	-83.99
Earnings Per Share	-13.62	-0.47	-1.85	-4.00	-4.02	-2.77
EPS Growth	-	-	-	-	-	-

Revenue by Segment

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Livmarli	400.59	360.01	213.3	141.8	75.06	3.14
Bile Acid Medicines	169.02	161.31	123.11	37.08	-	-
License and Other	-	-	0.48	7.5	2	16
Revenue (Total)	569.61	521.31	336.89	186.37	77.06	19.14

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	386.26	383.33	280.32	286.33	151.72	156.54
Total Debt	321.43	317.31	316.05	308.14	2.19	2.61
Net Cash (Debt)	64.83	66.01	-35.74	-21.82	149.53	153.93
Net Cash Growth	-	-	-	-	-2.86%	-32.65%
Net Cash Per Share	1.19	1.32	-0.75	-0.53	4.40	5.08

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-170.98	55.83	10.33	-70.94	-120.14	-132.76
Capital Expenditures	-1.58	-0.95	-0.99	-0.11	-0.28	-0.02
Free Cash Flow	-172.55	54.87	9.33	-71.05	-120.41	-132.78
Free Cash Flow Growth	-	488.01%	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	81.39%	80.77%	75.77%	74.76%	83.94%	90.06%
Operating Margin	-139.82%	-4.25%	-26.00%	-58.57%	-170.28%	-906.12%
Pretax Margin	-140.00%	-4.11%	-25.80%	-87.15%	-184.36%	-438.66%
Profit Margin	-140.24%	-4.48%	-26.10%	-87.68%	-176.05%	-438.86%
FCF Margin	-30.29%	10.53%	2.77%	-38.12%	-156.26%	-693.81%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
P/FCF Ratio	-	74.71	213.30	-	-	-
PS Ratio	12.05	7.86	5.91	7.40	9.20	25.49